BROADFIN CAPITAL, LLC Information

237 PARK AVENUE, 9TH FLOOR, NEW YORK, New York, 10017, (212) 808-2463

Report Date: 09/30/2014

Position Statistics

Total Positions 78
New Positions 10
Increased Positions 26
Decreased Positions 28
Positions with Activity 54
Sold Out Positions 8
Total Mkt Value (in $ millions) 996

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 0.53%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial 1.65%
Healthcare 87.45%
Services 1.26%
Technology
Transportation
Utilities

78 Positions as of 09/30/2014

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
NOVADAQ TECHNOLOGIES INC COM 2,806 -14,485 (83.77) 195,017
ONCOTHYREON INC COM 2,535 2,535 New 1,500,000
CELSUS THERAPEUTICS PLC SPONSORED ADR NE 2,425 New 470,877
ANTHERA PHARMACEUTICALS INC COM NEW 2,369 974 69.85 1,301,622
REDHILL BIOPHARMA LTD SPONSORED ADS 2,279 New 263,160
BIODEL INC COM NEW 2,115 New 1,330,034
RXI PHARMACEUTICALS CORP NEW COM NEW 2,084 New 1,126,482
TONIX PHARMACEUTICALS HLDG COR COM NEW 1,962 -1,358 (40.9) 276,394
IGNYTA INC COM 1,458 New 225,000
DIGIRAD CORP COM 1,257 New 332,480
AGENUS INC COM NEW -3,460 Sold Out 0
AUXILIUM PHARMACEUTICALS INC COM -10,050 Sold Out 0
BIOSCRIP INC COM -7,077 Sold Out 0
CAREFUSION CORP COM -7,281 Sold Out 0
HAEMONETICS CORP COM -133 Sold Out 0
LIPOCINE INC NEW COM -1,426 Sold Out 0
POZEN INC COM -5,845 Sold Out 0
SAGENT PHARMACEUTICALS INC COM -9,034 Sold Out 0